Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1409]

What are the endometrial cancer risks and trends among different African descent populations?

What are the endometrial cancer risks and trends among different African descent populations?

DNA test could broaden access to cervical cancer screening

DNA test could broaden access to cervical cancer screening

Researchers reveal mechanism of protection against breast and ovarian cancer

Researchers reveal mechanism of protection against breast and ovarian cancer

Ovarian cancer study identifies key genes for potential treatments

Ovarian cancer study identifies key genes for potential treatments

The use of genomic sequencing panels to personalise cancer treatment is beneficial in only 5% of the patients in whom they are currently used

The use of genomic sequencing panels to personalise cancer treatment is beneficial in only 5% of the patients in...

ASCO 2023: Trastuzumab deruxtecan effectively treats HER2-expressing cancers regardless of tumour location

ASCO 2023: Trastuzumab deruxtecan effectively treats HER2-expressing cancers regardless of tumour location

ASCO 2023: Targeted therapy achieves responses across multiple cancer types with FGFR alterations

ASCO 2023: Targeted therapy achieves responses across multiple cancer types with FGFR alterations

ASCO 2023: Antibody-microtubule inhibitor conjugate improves survival in women with recurrent ovarian cancer

ASCO 2023: Antibody-microtubule inhibitor conjugate improves survival in women with recurrent ovarian cancer

ASCO 2023: Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

ASCO 2023: Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

ASCO 2023: Global study finds simple hysterectomy a safe option for people with early-stage, low-risk cervical cancer

ASCO 2023: Global study finds simple hysterectomy a safe option for people with early-stage, low-risk cervical...

More from ecancer